BiotechTube
Home/ReGelTec/Peter Boyd, JD, MBA
PB

Peter Boyd, JD, MBA

CEO

ReGelTec

Therapeutic Areas

MusculoskeletalPain

ReGelTec Pipeline

DrugIndicationPhase
HYDRAFIL SystemChronic low back pain due to degenerative disc disease (DDD)Pivotal Trial (IDE)

Leadership Team at ReGelTec

DA
Dr. Anthony Lowman
CTO & Co-Founder
MC
Mark Collins, CPA
CFO
View full ReGelTec profile